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Abstract
Background: Although the prevalence of bronchiectasis decreased significantly in developed countries, in less
developed and in developing countries, it still represents a significant cause of morbidity and mortality. The aim of
this retrospective study is to present our surgical experiences, the morbidity and mortality rates and outcome of
surgical treatment for bronchiectasis.
Methods: We reviewed the medical records of 129 patients who underwent surgical resection for bronchiectasis
between April 2002 and April 2010, at Van Training and Research Hospital, Thoracic Surgery Department. Variables
of age, sex, symptoms, etiology, and surgical procedures, mortality, morbidity and the result of surgical therapy
were analyzed retrospectively.
Results: Mean age was 21.8 year (the eldest was 67 year, the youngest was 4 years-old). Male/female ratio was
1.86 and 75% of all patients were young population under the age of 40. Bilateral involvement was 14.7%, left/
right side ratio according to localization was 2.1/1. The most common reason for bronchiectasis was recurrent
infection. Surgical indications were as follows: recurrent infection (54%), hemoptysis (35%), empyema (6%), and
lung abscess (5%). There was no operative mortality. Complications occurred in 29 patients and the morbidity rate
was 22.4%. Complete resection was achieved in 110 (85.2%) patients. Follow-up data were obtained for 123 (95%)
of the patients. One patient died during follow-up. The mean follow-up of this patient was 9 months. Mean
postoperative hospitalization time was 9.15 ± 6.25 days. Significantly better results were obtained in patients who
had undergone a complete resection.
Conclusions: Surgical treatment of bronchiectasis can be performed with acceptable morbidity and mortality at
any age. The involved bronchiectatic sites should be resected completely for the optimum control of symptoms.
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Background
Bronchiectasis is defined as permanent dilatations of the
bronchi with destruction of the bronchial wall. Although
first described by Lannec at the beginning of the 19th
century, it is still an important problem especially in
some developing and underdeveloped countries [1].
Patients with early disease can be treated successfully by
conservative measures. In those with disease involving
multiple lobes of the lung or poor compliance with
long-term medical treatment, resection has a definitive
role in curing as well as improving the quality of life.
The current increase in tuberculosis rates is directly
related to insufficient and irregular medication. Addi-
tionally, irregular and inadequate treatment, the cessa-
tion of medication shortly after symptom improvement,
and a lack of check-ups after treatment are factors
accelerating recurrent pulmonary infection in developing
countries. Therefore, bronchiectasis continues to be a
major cause of morbidity and mortality in developing
countries as well as in Turkey [2,3]. We reviewed the
morbidity and mortality rates and outcome of surgical
treatment for bronchiectasis.
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A retrospective chart review was conducted of 129
patients who underwent surgical resection for bronch-
iectasis between April 2002 and April 2010. The patients
demographic features, the symptoms, etiologies and
resection types, morbidity, mortality and outcomes after
surgical management were analyzed. Patients were cho-
sen as candidates for surgical treatment according to the
following criteria: localized bronchiectasis documented
by high-resolution computed tomography (HRCT), ade-
quate cardiopulmonary reserve, symptoms such as
chronic productive cough, repeated or significant
hemoptysis, lung abscess, empyema, and recurrent pul-
monary infections, and failure of medical treatment.
Medical therapy constituted judicious use of systemic
antibiotics based on current sputum or bronchoscopic
lavage cultures, mucolytic agents, expectorants, postural
drainage, humidification, anti-inflammatory agents, and
bronchodilators. Fiberoptic bronchoscopy or rijit
bronchoscopy was performed in all patients to rule out
any intraluminal pathology. Failure of medical treatment
was defined as frequent exacerbations interfering with
normal professional and social life or requiring multiple
hospitalizations. The focus of hemorrhage was identified
bronchoscopically in patients with repeated or signifi-
cant hemoptysis, and, after the lungs were assessed by
HRCT, surgery was planned in patients who did not
respond adequate to conservative treatment.
A double-lumen endotracheal tube was used in all
patients to avoid a possible intraoperative contamination
of contralateral lobes and for thoracic surgery. Pulmon-
ary resection was achieved via a posterolateral thoracot-
omy. The decision for the volume of the resected lung
was based on radiologic findings rather than on thora-
cotomy. All specimens had pathologic confirmation of
bronchiectasis. Complete resection was defined as
removal of all affected segments. The bronchial stump
was closed using a mechanical stapler. The bronchial
stump was not reinforced with any other tissue. The
pulmonary resection was considered complete if the
patient was believed to be free of bronchiectasis after
thoracotomy. Operative mortality was defined as death
within 30 days after thoracotomy. Chest physiotherapy
was performed until discharge. All patients were given
specific or wide-spectrum antibiotic therapy.
After surgery, patients were observed by a team that
included chest physicians and surgeons. High-resolution
CT examinations were performed once a year. Clinical
data were calculated by the mean and standard devia-
tion. The influences of some variables on the prognosis
after the operation were studied by dividing the patients
into an improved group ("excellent” or “good” out-
comes) and an unimproved group ("no change” or
“worse” outcomes). Logistic regression analyses were
used to compare a variety of clinical factors between the
groups. Additionally, the association between potential
risk factors and postoperative complication was calcu-
lated. The parameters evaluated were patient demo-
g r a p h i c s ,s y m p t o m s ,i n d i c a t i o n sf o rs u r g e r y ,c h o i c eo f
surgical procedure, morbidity, mortality, and functional
outcome.
Results
There were 84 (65.1%) male and 45 (34.8%) female
patients; the average age of the 129 patients at thoracot-
omy was 21.8 years (range 4-67 years). The most com-
mon presenting symptoms were productive cough in 78
(60.4%) patients. There were 7 (5.4%) asymptomatic
patients. Although these patients were asymptomatic at
t h et i m eo fa d m i s s i o n ,t h e yh a dah i s t o r yo fr e c u r r e n t
pulmonary infections requiring medical therapy. The
mean duration of the symptoms was 25.6 months
(range, 1-135 months). One hundred two (79.00%)
patients had chronic symptoms present for a mean of
41.2 months (range, 6-146 months). There was a history
of tuberculosis in 18 (13.9%) patients. One hundred
twenty-two (94.5%) patients had respiratory function
tests, with the majority (79.5%) showing normal ventila-
tory patterns. The remainder showed a mixed or
obstructive ventilatory pattern. The logistic regression
analysis showed that a history of tuberculosis and
incomplete resection were independent predictors of the
operative result. Moreover, a forced expiratory volume
in 1 second of less than 60% of the predicted value, a
history of tuberculosis, and incomplete resection were
independent predictors of postoperative complications.
Posteroanterior and lateral chest radiographs were first
made as preoperative diagnostic studies in all patients.
HRCT was performed in all patients (100%). V/Q scinti-
graphy was performed in 11 patients (8.5%). On V/Q
scintigraphy, perfusion and ventilation were both
impaired, but ventilation was more affected. We have
been performing bronchoscopy on all patients preopera-
tively. The cause of secondary bronchiectasis in 8 of the
patients were central obstruction or stenosis. We had 7
patients with paranasal sinusitis. These patients had
nasal polyps due to chronic sinusitis. Before the opera-
tion, these cases were evaluated by a specialist, and 3 of
these 7 patients underwent operation. Afterward, they
were operated on for bronchiectasis. During their long
follow-ups, they had no problems, whereas the other 4
cases had occasional infections
Preoperative medical treatment, which included
appropriate antibiotic therapy and postural drainage,
was given and supervised by chest physicians. Sputum
was cultured for bacterial examination before surgery.
Sehitogullari et al. Journal of Cardiothoracic Surgery 2011, 6:161
http://www.cardiothoracicsurgery.org/content/6/1/161
Page 2 of 6Surgical treatment was considered if the medical treat-
ment failed. We considered that the treatment was a
failure if sputum production persisted despite several (3
or 4) courses of treatment or if there was a limited
extent of disease on CT. As a rule, the extent of dis-
eased lung to justify operation must be localized to
achieve complete resection. The decision for the volume
of the resected lung was based on radiologic findings
rather than on thoracotomy.
Hundred twenty-one (93.7%) patients had respiratory
function tests, with the majority (75.4%) showing normal
ventilatory patterns. The remainder showed a mixed or
obstructive ventilatory pattern. The 6-minute walk test
was performed along a level hospital corridor in 8
younger children. Arterial oxygen saturation (SaO2)w a s
measured by finger pulse oximetry before and during
the test and monitored continuously. Measurements
were recorded at 30-second intervals. All patients were
able to walk continuously for the 6-minute period. The
lowest SaO2 was used to calculate minimum SaO2.
Mean minimum SaO2 was 94.1. Care was taken to
ensure that SaO2 did not decrease below 90%. Along
with exercise, a 2% or greater desaturation was consid-
ered to represent a risk [4]. Three patient seen to be at
risk received 2 weeks of additional chest physiotherapy,
incentive spirometry, and ambulation with physical ther-
apy. The patient underwent surgery after this course of
treatment. No patient was observed to have effort dys-
pnea after the test.
Sputum culture and sensitivity showed no bacterial
growth in 61 (47.2%) patients, and mixed growth of
mainly gram-negative organisms in the others: Haemo-
philus influenzae in 24 (18.6%), Escherichia coli and
Klebsiella in 15 (11.6%), Pseudomonas in 6 (4.6%), and
Streptococcus pneumoniae in 4 (3.1%). Sputum acid-fast
bacillus was positive in 16 (12.4%) patients preopera-
tively; all were given antituberculous treatment and
underwent surgery once the sputum was negative (Table
1). The most common probable etiology was postob-
structive pneumonitis (Table 2). Pulmonary resection
was performed failure of medical therapy in 70 (54%)
patients, recurrent or massive hemoptysis in 45 (35%),
lung abscess in 6 (5%), and empyema in 8 (6%).
Thoracotomy was performed in all patients. The dis-
ease was bilateral in 19 patients (14.7%) and mainly con-
fined to the lower lobe in 72 (55.8%). The mean number
of segments involved was 3.1 (range, one to 9 segments).
Surgical treatment included lobectomy (lobectomy,
lobectomy ± segmentectomy, lobectomy ± wedge resec-
tion) in 105 patients (81.3%), pneumonectomy in 8
(6.2%), wedge resection or segmentectomy in 16
(12.4%), and a combination of these approaches in 38
(29.4%). Disease was considered completely resected in
110 patients (85.2%) (Table 3).
Of the 45 patients with hemoptysis, 3 had massive
hemoptysis. These 3 patients underwent surgery after
bronchoscopic evaluation and intervention. Massive
hemoptysis was defined as expectorating more than 600
mL of blood in 24 hours. A rigid broncoscope was used
under emergency conditions to determine the location
of hemorrhage in patients with massive hemoptysis. Irri-
gation with physiologic saline with ice was performed to
stop the bleeding. Then the bleeding bronchus was
Table 1 Microbiologic culture results of the patients
Microorganism n %
Haemophilus influenzae 24 18.6
asit-fast bacillus 16 12.4
Streptococcus pneumoniae 4 3.1
Pseudomonas aeruginosa 6 4.6
Bacteroides and other anaerobes 3 2.3
Klebsiella and Escherichia coli 15 11.6
Negative culture 61 47.2
Table 2 Etiologic factors of bronchiectasis
Etiology n (%)
Postobstructive pneumonitis 28 (21.7%)
Pneumonia 21 (16.2%)
Tuberculosis 18 (13.9%)
Childhood infections 18 (13.9%)
Foreign body aspiration 5 (3.8%)
Pulmonary sequestration 1 (0.7%)
Unknown etiology 38 (29.4%)
Table 3 Surgical procedures in 129 patients with
bronchiectasis
Procedure No. of
Patients
Pneumonectomy
Left 5 (3.8%)
Right 3 (2.3%)
Lobectomy
Right upper lobe 4 (3.1%)
Right middle lobe 13(10.0%)
Right lower lobe 11 (8.5%)
Left upper lobe 5 (3.8%)
Left lower lobe 40 (31.0%)
Lingulectomy or segmentectomy+ wedge
resection
(bilateral) 6(4.6%)
Lobectomy ± segmentectomy (Bilateral)
Bilobectomy
3 (2.3%)
Right upper lobe + right middle lobe 7 (5.4%)
Right middle lobe + right lower lobe 5 (3.8%)
Left upper lobe + lingula 3 (2.3%)
Left lower lobe + lingula 14 (10.8%)
Bilateral segmentectomy 10 (7.7%)
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tube. In 2 of these 3 patients, the focus of hemorrhage
was clearly detected; in the third the hem-orrhage could
not be exactly localized. HRCT revealed signs of
destroyed lung that required left pneumonectomy.
Complications occurred in 29p a t i e n t s( 2 2 . 4 % )a n d
included atelectasis requiring bronchoscopy in 7, a pro-
longed air leak (greater than 10 days) in 5, empyema in
5, pneumonia in 4, postoperative hemorrhage requiring
reexploration in 3, arrhythmias in 2, postpneumonect-
omy pulmonary edema in 1, respiratory failure in 1, and
bronchopleural fistula in 1 (Table 4). One patients
(0.7%) who underwent pneumonectomy died 9 month
later, The cause of death was respiratory failure in
patients.
Follow-up was complete in 123 patients, with a mean
of 5.3 years (range, 1 to 8 years). Overall, 74 patients
(60.1%) were asymptomatic after pulmonary resection.
Symptoms were improved and antibiotic requirements
were decreased in 35 patients (28.4%). Fourteen patients
(11.3%) had no improvement. In the group that had a
complete resection, 105 patients were available for fol-
low-up. Seventy (66.6%) were asymptomatic, 28 (26.6%)
were improved, and 7 (6.6%) were unimproved. In the
group that had an incomplete resection, 18 were avail-
able for follow-up. Four (22.2%) were asymptomatic, 7
(38.8%) were improved, and 7 (38.8%) were unimproved.
Complete resection resulted in a significantly better
result than incomplete resection (p < 0.05).
Discussion
In developing countries, bronchiectasis is still common
and is a significant major cause of morbidity and mor-
tality [5]. As the disease progresses, physical activities
become increasingly limited, patients fail to thrive, and
ultimately they suffer from social deprivation, intrinsic
depression, and respiratory failure. Although antibiotics
and postural drainage are widely applied in the medical
management of the disease, resection of the involved
segment remains the only treatment modality that can
offer a potential cure [6]. Proper treatment of early
chest infections during childhood and improved health
awareness may have contributed to the reduction of the
incidence of bronchiectasis in the developed countries.
In our series, a predisposing cause was identified in 16
patients (12.4%), predominantly previous tuberculosis
infection; however, most cases remained idiopathic.
Chronic respiratory infections, especially if acquired in
childhood, play an important role in the etiology of
bronchiectasis. The majority of patients with bronchiec-
tasis have a history of childhood infections or recurrent
pneumonia, with rates as high as 77.7% reported in the
literature [7]. In our series, 46 (35.6%) patients had post-
obstructive pneumonitis plus a history of pulmonary
infection in childhood. Currently, it is understood that
adequate treatment of childhood infections is the most
important factor to prevent this irreversible disease. In
the series Özdemir et al. [4]; developed bronchiectasis
reported more frequently in low socioeconomic level in
humans. Our series found a significant decrease in the
number of patients who underwent surgical treatment
for bronchiectasis over the years in our country. This
decrease may be associated with improvements in health
care. Bronchiectasis is usually caused by bronchopul-
monary infection or bronchial obstruction; approxi-
mately half of patients can trace the onset of symptoms
to a childhood infection. Primarily the symptoms are
chronic cough and fetid sputum. In our series, Haemo-
philus influenzae and asit-fast bacillus were the most
common organisms isolated from sputum.
The incidence and surgical importance of bronchiecta-
sis has decreased in developed countries following the
successful control of childhood infections [1,8]. But it
remains surgically important in developing countries.
We noted a marked reduction in the annual number of
patients with bronchiectasis in our series. Despite
advances in thoracic surgery, the optimal treatment for
bronchiectasis remains controversial [3,9]. There is a
broad consensus concerning the indications for surgical
resection. Most physicians and surgeons reserve this
treatment for localized bronchiectasis [10]. Multiseg-
mental or bilateral bronchiectasis is generally regarded
as a contraindication for surgery [11,12]. Nevertheless,
we are confronted with cases of bronchiectasis involving
multiple segments and lobes, with failure of conservative
therapy, for which surgical intervention may be consid-
ered. In our study, 10 of 19 patients with bilateral
bronchiectasis were successfully treated by staged
thoracotomy.
Pulmonary function studies were performed in 122
(94.5%) of our patients. As was the case with other ser-
ies [2,13,14], we found a normal ventilatory pattern in
the majority of patients (79.5%). The remainder showed
a mixed or obstructive ventilatory pattern. In 25 (14.1%)
Table 4 Complications after surgery for bronchiectasis
Complication No. of Patients
Bronchopleural fistula 1 (0.7%)
Postoperative bleeding 3 (2.3%)
Respiratory failure 1 (0.7%)
Empyema 5 (3.8%)
Prolonged air leak (> 10 day) 5 (3.8%)
Pulmonary edema 1 (0.7%)
Arrhythmias 2 (1.5%)
Atelectasis 7 (5.4%)
Pneumonia 4 (3.1%)
Total 29 (22.4%)
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(< 60% of the predicted value), the postoperative com-
plication rate was significantly high. This indicated that
surgery should be delayed in cases of severe inflamma-
tion until adequate control has been achieved. In addi-
tion, the preoperative treatment should include reducing
airway obstruction and eliminating microorganisms
from the lower respiratory tract, which consists of anti-
microbial therapy, postural physiotherapy, bronchodila-
tors, and corticosteroids [3].
The goals of surgical therapy for bronchiectasis are to
improve the quality of life for those patients in whom
medical treatment has failed and to resolve complica-
tions such as empyema, severe or recurrent hemoptysis,
and lung abscess [3,15]. Complete and anatomic resec-
tion should be done with preservation of as much lung
function as possible to avoid cardiorespiratory limitation
[16]. It was reported that the symptoms persisted when
incomplete resection was carried out [17]. We per-
formed complete resection in 85.2% of our patients, and
preoperative symptoms resolved completely in 67.0%
and improved in 25.7% (92.7% benefited from the opera-
tion). In the light of these findings, we suggest that
complete resection should be per-formed for the surgi-
cal treatment of bronchiectasis and that incomplete
resection should only be used for the palliative treat-
ment of certain life-threatening symptoms.
Postoperative complications were observed in 12.7% of
patients who underwent complete resection and in 79%
of those who underwent incomplete resection. When
suggestive lung regions are not excised, with the aim of
sparing as much lung tissue as possible, more post-
operative complications occur and a second operation
that carries a higher morbidity and mortality might be
required to remove the residual diseased tissues [18].
Therefore, we suggest that, during intraoperative exami-
nations, if suggestive areas that could not be determined
by radiologic examination are present, these parenchy-
mal areas should be resected to perform complete
resection.
Complications usually range between 9.4% and 24.6%
[10,15,19]. We reported 22.4% complication rate, mainly
related to bleeding and prolonged air leak, emphasizing
the need for good hemostasis and careful dissection. In
our cases of mixed bilateral localized bronchiectasis,
most of the patients had improvement with low morbid-
ity after resection of the localized areas. In cases of
bilateral cystic bronchiectasis, the role of surgery is lim-
ited to life-threatening complications as a palliative mea-
sure and such patients should be listed for lung
transplantation if respiratory failure occurs [20].
Complete resection of bronchiectatic parenchyma
while saving as much normal lung parenchyma as possi-
ble is the mainstay of surgical treatment. This aim can
be achieved by lobectomy in most patients, but other
resection types, such as wedge or segmental resection,
can also be used in less affected areas. In the series of
Dogan et al. [16], 41.5% of patients underwent lobect-
omy, 4.7% had a bilobectomy, and 14.8% underwent
lobectomy + wedge resection. In the series of Agasthian
et al. [3], lobectomy was the commonest type of resec-
tion with a rate of 64.2% (n = 134). In general, bronch-
iectasis affects the most dependent lung areas such as
the basal segments of the lower lobes, the middle lobe
or lingula. In our series bronchiectasis was confined to
only one lobe in 73 (56.6%) patients. Therefore lobect-
omy was the most common type of resection performed
in our series. Pneumonectomy was done in 12 patients,
predominantly as expected on the left side because of
the anatomy of left bronchus syndrome [21]. In our ser-
ies was similar that in the literature.
At follow-up, 7 (38.8%) patients were found to have
no change or worse symptoms than preoperatively, of
whom 18 (94.7%) had incomplet resection; however,
93.3% had complet resection in the group with
improved symptoms. Previous studies have shown var-
ious causes for persistent symptoms after resection
[22,23]. In our series; Relations between clinical vari-
ables and operative results as follows; the p-value for
duration of symptoms was 0,506, for a positive culture
was 0,135, for FEV 1 was 0,205, for complete/incom-
plete resection was 0.000. In patients who undergoing
complete resection operative results were significantly
better, and less morbidity.
Follow-up was complete in 123 (95.3%) patients with a
mean of 5.3 years (range, 1 to 8 years). Seventy-four
(60.1%) patients were free of symptoms after surgical
treatment, symptoms were improved in 35 (28.1%), and
were unchanged or worse in 14 (11.3%). Of the patients
who underwent complete resection, 93.2% benefited
from the operation and, of those who underwent incom-
plete resection, only 61.1% benefited. The logistic
regression analysis showed that tuberculosis history and
incomplete resection were independent predictors of the
none improvement group. Moreover, a forced expiratory
volume in 1 second was less than 60% of the predicted
value, tuberculosis history, and incomplete resection
were independent predictors of postoperative complica-
tions (Tables 5).
Pulmonary resection can be performed with accepta-
ble morbidity and mortality rates in properly selected
patients. The morbidity rate reported in the literature is
around 25% [3.24]. Common complications include
atelectasis, hemorrhage, empyema, respiratory failure
and bronchopleural fistula. The complication rate in our
series was 22.4%, similar to that in the literature.
Reported mortality rates in the literature range between
1 and 3% [3]. Our mortality rate was 0.7% which can be
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(The mean follow-up of this patient was 9 months).
Conclusions
Pulmonary resection for bronchiectasis can be done
with low mortality and morbidity. The involved bronch-
iectatic sites should be resected completely for the opti-
mum control of symptoms.
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Table 5 Relation between clinical variables and
postoperative complications
Variables OR 95% CL P Value
Gender (male:female), 0.584 0.248-1.376 .219
Age (< 17: > 17 ys) 1.926 0.728-5.108 .268
Symptoms duration (< 12: > 12 m) 1.256 0.465-3.392 .653
Positive culture (present:absent) 1.025 0.466-2.253 .951
FEV1(value < 60%: > 60 predicted) 0.164 0.059-0.458 .001
Type of resection 0.031 0.010-0.096 .000
(complete: incomplete)
Tuberculosis (presentabsent) 0.052 0.025-1.345 .001
OR, Odds ratio; CI, confidence interval; FEV1, forced expiratory volume in 1
second.
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